Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:11
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
[21]   Local Recurrence following Radiological Complete Response in Patients Treated with Subsegmental Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma [J].
Gwon, Dong Il ;
Kim, Gun Ha ;
Chu, Hee Ho ;
Kim, Jin Hyoung ;
Ko, Gi-Young ;
Yoon, Hyun-Ki .
CANCERS, 2023, 15 (20)
[22]   Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography [J].
Miyayama, Shiro ;
Matsui, Osamu ;
Zen, Yoh ;
Yamashiro, Masashi ;
Hattori, Yuki ;
Orito, Nobuaki ;
Matsui, Ken ;
Tsuji, Kazunobu ;
Yoshida, Miki ;
Sudo, Yoshiko .
HEPATOLOGY RESEARCH, 2011, 41 (09) :853-866
[23]   Four-dimensional flow MR imaging for evaluating treatment response after transcatheter arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma [J].
Moon, Chung Man ;
Lee, Yun Young ;
Kim, Seul Kee ;
Jeong, Yong Yeon ;
Heo, Suk Hee ;
Shin, Sang Soo .
RADIOLOGIA MEDICA, 2023, 128 (10) :1163-1173
[24]   The value of dynamic subtraction MRI technique in the assessment of treatment response of hepatocellular carcinoma to transcatheter arterial chemoembolization [J].
Metwally, Lamiaa I. A. ;
Mahmoud, Bahaa Eldin ;
Yehia, Mahmoud .
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01)
[25]   Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase [J].
Saake, Marc ;
Lell, Michael M. ;
Eller, Achim ;
Wuest, Wolfgang ;
Heinz, Marco ;
Uder, Michael ;
Schmid, Axel .
ACADEMIC RADIOLOGY, 2015, 22 (12) :1516-1521
[26]   Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization [J].
Drewes, Ralph ;
Heinze, Constanze ;
Pech, Maciej ;
Powerski, Maciej ;
Woidacki, Katja ;
Wienke, Andreas ;
Surov, Alexey ;
Omari, Jazan .
DIGESTIVE DISEASES, 2022, 40 (05) :596-606
[27]   Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy A retrospective study [J].
Li, Wei ;
Wang, Yang ;
Gao, Wenfeng ;
Zheng, Jiasheng .
MEDICINE, 2016, 95 (47)
[28]   Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma [J].
Li, Sheng ;
Zhang, Liang ;
Huang, Zhi-Mei ;
Wu, Pei-Hong .
CHINESE JOURNAL OF CANCER, 2015, 34
[29]   Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases [J].
Yun Jeung Kim ;
Pyung Gohn Goh ;
Hee Seok Moon ;
Eaum Seok Lee ;
Seok Hyun Kim ;
Byung Seok Lee ;
Heon Young Lee .
World Journal of Radiology, 2012, (05) :236-240
[30]   β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization [J].
Xu, Xiangxian ;
Gao, Dazhi ;
Yuan, Xiaoli ;
Liu, Li ;
Zhang, Xiang ;
Liang, Xianxian ;
Chen, Sui ;
Ai, Min ;
Chen, Bo ;
Shi, Donghong ;
Yang, Zhijian ;
Hoffman, Robert M. ;
Xu, Jian .
ANTICANCER RESEARCH, 2019, 39 (03) :1129-1134